Atlas Trials

Study of Intravenous Erenumab in Patients With Status Migrainosus

Clinical trial NCT04920331 · WITHDRAWN

Trial details

NCT number
NCT04920331
Sponsor
Mayo Clinic
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Status Migrainosus
Start date
2021-09-07
Primary completion
2022-02-04
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.